Progyny, Inc.

PGNY

$26.24

Updated: 23/09/2026, 09:59:51

Market Cap

$2.06B

Sector

Healthcare

Industry

Medical - Healthcare Plans

Country

Stock valuation chart

One-year closing share-price history for PGNY

Company Profile

Progyny, Inc. functions as a benefits management corporation, dedicated to providing specialized solutions for fertility and broader family-building initiatives to employers throughout the United States. Its core fertility offering is characterized by a distinctive benefits plan architecture, paired with personalized, white-glove member support services and access to a meticulously chosen network of top-tier fertility specialists. Additionally, the company presents Progyny Rx, an all-encompassing pharmacy benefits solution that ensures its members can readily acquire the essential medications for their treatments. Moreover, Progyny facilitates employer-sponsored reimbursement programs to support surrogacy and adoption journeys. The company, which was established in 2008 and has its main offices in New York City, previously operated as Auxogyn, Inc. before adopting the Progyny, Inc. moniker in 2015.

USD

NASDAQ

CEO: Pete Anevski

Employees: 846

https://www.progyny.com

Asset Summaries

Latest generated summaries for PGNY

No summaries found.

Detailed business

Structured knowledge from the latest official annual filing.

No official annual filing has completed ingestion for this company yet. The filing worker processes major-index companies incrementally and never repeats a completed fiscal year.

Full company information

Latest profile, trading, valuation, and identifier data stored for PGNY.

Share price: $26.24
Market cap: $2.06B
Exchange: NASDAQ
Currency: USD
CEO: Pete Anevski
Employees: 846
IPO date: 25/10/2019
Beta: 0.991
Last dividend: $0.00
Day range: $26.16 – $27.15
52-week range: $16.10 – $33.07
1-day performance: -2.31%
1-year performance: 62.98%
Current drawdown (1Y): -20.64%
CIK: 0001551306
CUSIP: 74340E103
ISIN: US74340E1038
Created: 07/12/2025, 05:44:11
Last update: 23/09/2026, 09:59:51

Track Progyny, Inc. with an AI analyst

See which prediction-market events move PGNY, how its filings map to real-world exposure, and what 12 AI strategies are doing with positions like it.

Create a free account See what the world decides next

Free forever to follow AlphaBrain’s AI strategies. No card required.

Latest Database News

News linked to PGNY from your Railway `news_articles` table.

A Look at Progyny Inc (PGNY) After 3.8% Gain -- GF Value $28.04 vs Price $26.63

GuruFocus • STOCK • 12/06/2026, 21:28:00

A Progyny (PGNY) Insider Sold 5,500 Shares for $137,000

Fool - Investing News • STOCK • 31/05/2026, 13:02:49

Progyny, Inc. (PGNY) Shareholder/Analyst Call Transcript

Seeking Alpha • STOCK • 21/05/2026, 18:40:44

Bull of the Day: Progyny (PGNY)

Zacks Investment Research • STOCK • 18/05/2026, 07:01:08

Progyny (PGNY) Financials Impress, Analyst Price Target Rises

Market Data • Market Data • 16/05/2026, 02:04:16

Progyny (NASDAQ: PGNY) Price Target Raised Amidst Strong Financial Performance

Market Data • Market Data • 15/05/2026, 22:17:13

Progyny, Inc. (PGNY) Presents at Bank of America Global Healthcare Conference 2026 Transcript

Seeking Alpha • STOCK • 12/05/2026, 19:00:57

Progyny, Inc. to Present at BofA Securities 2026 Health Care Conference

GlobeNewsWire • STOCK • 11/05/2026, 12:57:00

Progyny Q1 Earnings Call Highlights

MarketBeat • STOCK • 08/05/2026, 18:03:17

Progyny, Inc. (PGNY) Q1 2026 Earnings Call Transcript

Seeking Alpha • STOCK • 08/05/2026, 06:02:23

PGNY or ALHC: Which Is the Better Value Stock Right Now?

Zacks Investment Research • STOCK • 28/04/2026, 14:41:28

Progyny, Inc. Announces Details for Its First Quarter 2026 Results Report

GlobeNewsWire • STOCK • 23/04/2026, 15:55:00